Cell Therapy Bigwigs Endorse CAR-T in Nature Medicine Article Amid FDA Safety Probe
Jan 9, 2024 | By Angus Liu
As an FDA investigation into patients developing secondary T-cell cancers rocked the CAR-T world, a group of cell therapy experts, including CAR-T pioneers Bruce Levine, Ph.D., and Carl June, M.D., are lending their support to the emerging immunotherapy in a commentary published in Nature Medicine.